EconPapers    
Economics at your fingertips  
 

Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAFV600 melanoma

Lorey K. Smith (), Tiffany Parmenter, Margarete Kleinschmidt, Eric P. Kusnadi, Jian Kang, Claire A. Martin, Peter Lau, Riyaben Patel, Julie Lorent, David Papadopoli, Anna Trigos, Teresa Ward, Aparna D. Rao, Emily J. Lelliott, Karen E. Sheppard, David Goode, Rodney J. Hicks, Tony Tiganis, Kaylene J. Simpson, Ola Larsson, Benjamin Blythe, Carleen Cullinane, Vihandha O. Wickramasinghe, Richard B. Pearson and Grant A. McArthur ()
Additional contact information
Lorey K. Smith: Cancer Research Division, Peter MacCallum Cancer Centre
Tiffany Parmenter: Cancer Research Division, Peter MacCallum Cancer Centre
Margarete Kleinschmidt: Cancer Research Division, Peter MacCallum Cancer Centre
Eric P. Kusnadi: Cancer Research Division, Peter MacCallum Cancer Centre
Jian Kang: Cancer Research Division, Peter MacCallum Cancer Centre
Claire A. Martin: Cancer Research Division, Peter MacCallum Cancer Centre
Peter Lau: Cancer Research Division, Peter MacCallum Cancer Centre
Riyaben Patel: Cancer Research Division, Peter MacCallum Cancer Centre
Julie Lorent: Karolinska Institutet
David Papadopoli: McGill University
Anna Trigos: Cancer Research Division, Peter MacCallum Cancer Centre
Teresa Ward: Cancer Research Division, Peter MacCallum Cancer Centre
Aparna D. Rao: Cancer Research Division, Peter MacCallum Cancer Centre
Emily J. Lelliott: Cancer Research Division, Peter MacCallum Cancer Centre
Karen E. Sheppard: Cancer Research Division, Peter MacCallum Cancer Centre
David Goode: Cancer Research Division, Peter MacCallum Cancer Centre
Rodney J. Hicks: Cancer Research Division, Peter MacCallum Cancer Centre
Tony Tiganis: Cancer Research Division, Peter MacCallum Cancer Centre
Kaylene J. Simpson: Cancer Research Division, Peter MacCallum Cancer Centre
Ola Larsson: McGill University
Benjamin Blythe: Cancer Research Division, Peter MacCallum Cancer Centre
Carleen Cullinane: Cancer Research Division, Peter MacCallum Cancer Centre
Vihandha O. Wickramasinghe: Cancer Research Division, Peter MacCallum Cancer Centre
Richard B. Pearson: Cancer Research Division, Peter MacCallum Cancer Centre
Grant A. McArthur: Cancer Research Division, Peter MacCallum Cancer Centre

Nature Communications, 2022, vol. 13, issue 1, 1-21

Abstract: Abstract Despite the success of therapies targeting oncogenes in cancer, clinical outcomes are limited by residual disease that ultimately results in relapse. This residual disease is often characterized by non-genetic adaptive resistance, that in melanoma is characterised by altered metabolism. Here, we examine how targeted therapy reprograms metabolism in BRAF-mutant melanoma cells using a genome-wide RNA interference (RNAi) screen and global gene expression profiling. Using this systematic approach we demonstrate post-transcriptional regulation of metabolism following BRAF inhibition, involving selective mRNA transport and translation. As proof of concept we demonstrate the RNA processing kinase U2AF homology motif kinase 1 (UHMK1) associates with mRNAs encoding metabolism proteins and selectively controls their transport and translation during adaptation to BRAF-targeted therapy. UHMK1 inactivation induces cell death by disrupting therapy induced metabolic reprogramming, and importantly, delays resistance to BRAF and MEK combination therapy in multiple in vivo models. We propose selective mRNA processing and translation by UHMK1 constitutes a mechanism of non-genetic resistance to targeted therapy in melanoma by controlling metabolic plasticity induced by therapy.

Date: 2022
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-022-28705-x Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-28705-x

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-022-28705-x

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-28705-x